RELESTAT

This brand name is authorized in Austria, Brazil, Spain, Hong Kong, Ireland, Israel, New Zealand, Poland, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug RELESTAT contains one active pharmaceutical ingredient (API):

1 Epinastine UNII GFM415S5XL - EPINASTINE HYDROCHLORIDE

Epinastine is a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from the mast cell. Epinastine is selective for the histamine H1-receptor and has affinity for the histamine H2receptor. Epinastine also possesses affinity for the α1, α2, and 5-HT2–receptors. Read about Epinastine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RELESTAT Eye drops, solution	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01GX10	Epinastine	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501006101135311, 501006102131311
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 65574
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 56514
Country: HK	Department of Health Drug Office	Identifier(s): 53472
Country: IE	Health Products Regulatory Authority	Identifier(s): 43652
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4942
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11284
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100134915
Country: SG	Health Sciences Authority	Identifier(s): 13817P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699490561232
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/15.4/0691